EVALUATION OF SAFETY AND EFFICACY OF A POLY HERBAL FORMULATION ADATHODAI CHOORANAM IN IYA ERAIPPU NOI(BRONCHIAL ASTHMA)
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 125
- 试验地点
- 1
- 主要终点
- Moderate response
研究概览
简要总结
It is a single, non-randomized, open-label trial to determine the efficacy and safety of ADATHODAI CHOORANAM in patients with IYA ERAIPPU NOI (BRONCHIAL ASTHMA). The trial drug Adathodai Chooranam is a herbal formulation taken from the classical Siddha text Book ‘Sigitcha Rathna Deepam Enum Vaidhya Nool’ Page No.118 & 119 which is a approved text Book of Drug and Cosmetics Act 1940.In this trial 125 Bronchial asthma patients will be recruited and the trial drug will be administered 1.5 gm twice a day along with milk for a period of 30 days. During this trial period all the study related data will be recorded and documented in a separate trial master file for each patients.During the trial period if any AE/SAE/SUSAR will be noticed and referred to pharmacovigilance dept.in NIS and further management will also be given in NIS OPD/IPD. The entire trial will be monitored by the research monitoring committee OF NIS. During this trial all the safety and efficacy parameters will be recorded in the CRF. After completion of the trial all the study related data will be analysed statistically .The out come of this trial will be published in Indian Journal of Medical Research.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 15.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Patients who are having classical symptoms of Bronchial Asthma that difficulty in breathing, Tightness of Chest, Wheezing, Dry (or) Productive Cough, 2.Only new patients will be included.
- •3.Aged between 15 to 60 years of both sexes.
- •4.Willing to give blood specimen, sputum, Radiological Investigation and Willing to be admitted in the hospital (or) attend the OPD once a week for 3 weeks.
- •5.Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using peak flow meter.
排除标准
- •1.Pregnancy and Lactation period.
- •2.Significant Systemic illness including Cardiac Diseases, Renal Diseases, Hypertension.
- •3.Patients with only nasal block or rhinorrhoea.
- •4.Other respiratory Diseases such as Tuberculosis, Pneumonia, COPD,Bronchiectasis, cystic fibroisis, 5.Endocrine Disorders like Hypo & Hyper Thyroidism, Diabetes Mellitus 6.Status Asthmaticus.
结局指标
主要结局
Moderate response
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Poor response
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Outcome
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Step3Step1/Step2/Normal
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
PEEK EXPIRATORY FLOW MEASUREMENT
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Good response
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Step4 Step1/Step2/Normal
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
Step4 to Step3
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
no Significant
时间窗: PRE STUDY SCREENING AND AFTER 30 DAYS OF TREATMENT
次要结局
- Eosinophils and ESR,(AEC, Serum IgE level)
